Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Return on Capital Employed (2016 - 2025)

PAVmed has reported Return on Capital Employed over the past 5 years, most recently at 92.39% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 74146.0% year-over-year to 92.39%; the TTM value through Dec 2025 reached 92.39%, down 74146.0%, while the annual FY2025 figure was 109.58%, 136045.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 92.39% at PAVmed, down from 66.16% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 1157.5% in Q3 2023 and troughed at 1010.82% in Q1 2023.
  • A 5-year average of 26.81% and a median of 93.56% in 2025 define the central range for Return on Capital Employed.
  • On a YoY basis, Return on Capital Employed climbed as much as 139988bps in 2023 and fell as far as -91406bps in 2023.
  • Year by year, Return on Capital Employed stood at 94.73% in 2021, then tumbled by -337bps to 413.61% in 2022, then soared by 200bps to 414.25% in 2023, then surged by 57bps to 649.07% in 2024, then crashed by -114bps to 92.39% in 2025.
  • Business Quant data shows Return on Capital Employed for PAVM at 92.39% in Q4 2025, 66.16% in Q3 2025, and 76.7% in Q2 2025.